Cargando…
Mechanisms of action of metformin with special reference to cardiovascular protection
Management guidelines continue to identify metformin as initial pharmacologic antidiabetic therapy of choice for people with type 2 diabetes without contraindications, despite recent randomized trials that have demonstrated significant improvements in cardiovascular outcomes with newer classes of an...
Autores principales: | Zilov, Alexey V., Abdelaziz, Sulaf Ibrahim, AlShammary, Afaf, Al Zahrani, Ali, Amir, Ashraf, Assaad Khalil, Samir Helmy, Brand, Kerstin, Elkafrawy, Nabil, Hassoun, Ahmed A.K., Jahed, Adel, Jarrah, Nadim, Mrabeti, Sanaa, Paruk, Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851752/ https://www.ncbi.nlm.nih.gov/pubmed/31021474 http://dx.doi.org/10.1002/dmrr.3173 |
Ejemplares similares
-
Optimising the medical management of hyperglycaemia in type 2 diabetes in the Middle East: pivotal role of metformin
por: Al-Maatouq, M, et al.
Publicado: (2009) -
Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
por: AlHabeeb, Waleed, et al.
Publicado: (2021) -
β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
por: Pathak, Atul, et al.
Publicado: (2021) -
Cecal volvulus following mini gastric bypass: A case report and review of literature
por: Alghamdi, Hanan M., et al.
Publicado: (2018) -
Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction
por: Razvi, Salman, et al.
Publicado: (2019)